Status:
TERMINATED
Exploring Psychometric Properties of a New Version of the 6MWT in the Acute Stroke Population
Lead Sponsor:
Mayo Clinic
Conditions:
Acute Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess inter- and intra-rater reliability of the 6MWT in people with acute stroke who require various levels of assistance with walking.
Eligibility Criteria
Inclusion
- At least 18 years old
- Primary diagnosis of an acute or hemorrhagic stroke
- Admitted into the acute or acute rehab setting and is appropriate for physical therapy services.
- Can ambulate with 1 person assistance and a device as needed, with no more than maximal assistance required. The patient must be able to independently advance the lower extremity forward, but can receive maximal assistance for blocking, bracing or postural control during ambulation.
- Can stand and/or ambulate for at least 6 minutes
Exclusion
- Hemodynamically unstable
- Unstable medical co-morbidities such as: active bleeding, recurring seizures, uncontrolled hypertension (permissive HTN orders ok)
- Patients with bilateral acute stroke
- Patients who are unable to follow 1 step commands as determined by the screening physiatrist
- Orthopedic co-morbidities that place a weight-bearing restriction on the lower extremities such as acute fracture, joint replacement, or other musculoskeletal injury
- Any other condition that would limit a patient's ability to remain in a standing position with assistance for 6 minutes at a time.
Key Trial Info
Start Date :
March 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2020
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT04515693
Start Date
March 25 2020
End Date
October 31 2020
Last Update
July 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85054